Fredrik Löndahl was 17 years old when diagnosed with diabetes type-1. That was the start for a strong interest in and dedication to reducing ignorance and prejudices about diabetes. Today he is chairman of the Swedish Diabetes Association, a patient organization that supports research and works to find causes and cures for diabetes diseases.
A stone's throw away from Stora torget in Malmö is the Administrative Court. Here Fredrik Löndahl works as chief district court judge. He is a lawyer and combines his work with the task of being the chairman of the Swedish Diabetes Association.
– It works well because the assignment is part-time. I can be flexible and work weekends and evenings and I can also read a lot when I commute between the job in Malmö and my home in Helsingborg.
With his professional background as a lawyer, he has an advantage in communicating with authorities and interpreting strict laws and regulations. And with his own experience of diabetes type-1, he is well acquainted with what it means to live with the disease. And just like many others with diabetes, Fredrik also meets ignorance and prejudice. There is a lot left to do, he believes, to raise awareness and increase the level of knowledge regarding diabetes diseases.
– We have good diabetes care in Sweden and research of international top class. However, there are still big challenges. Many live with diabetes without knowing, and we have a long way to go in order to create equal and equitable access to care and treatment. By killing myths and spreading information and knowledge about diabetes, we hope that awareness will increase. We also support research through the Diabetes Foundation and we have a continuous dialogue with the profession, says Fredrik Löndahl.
Diabetes is the world's fastest growing widespread disease. A common estimate is that about four percent of the Swedish population has diabetes. It is a complex disease and much remains unclear when it comes to underlying disease mechanisms. However, much has happened since the hormone insulin was discovered in 1921. If you had diabetes as a ten year old in the early 20th century, you usually survived only one year after diagnosis. Since then, life expectancy has increased by over 57 years, much thanks to research and improved treatment options. But also through in-depth knowledge of the impact and importance of lifestyle factors.
– Even if we have come a long way, many questions remain to be answered. In both type-1 and type-2 diabetes, heredity plays an important role, but genetics explain far from everything. If I take myself as an example, I have a mother with type-1 diabetes and I got the diagnosis when I was 17 years old. One can easily believe that heredity plays a major role in type-1, but in fact, only a fraction of those who have a type-1 heredity actually get sick.
There are several known risk genes that increase the vulnerability of the individual to diabetes. But it usually takes a combination of heredity and environmental factors for the disease to be triggered. One hypothesis is that viral infections can trigger the autoimmune procedure that can lead to type-1 diabetes in genetically vulnerable individuals.
– We also need to learn more about the different types of diabetes. It is probably not just a disease but several and in the future we will probably get a much better classification.
In early 2018, a research group in Lund received great international attention. In an article in the reputed scientific journal "The Lancet Diabetes & Endocrinology," the research group, led by Professor Leif Groop, hypothesized that today's diagnosis and classification of diabetes is insufficient. A refined diagnosis classification with five types of diabetes was proposed instead of the current two. The main difference from today's classification is that type-2 diabetes consists of several subgroups.
– This is very important research and the new diagnosis classification increases the possibility of predicting the risk of serious complications and aids in choosing treatment, says Fredrik Löndahl.
Each year, the Diabetes Foundation allocates funding to researchers who carry out projects that address various aspects of diabetes. The allocation of funding differs from year to year. It is the Diabetes Foundation's scientific council that assesses the research projects based on scientific quality.
– The hope is, of course, that researchers will find the answer to the diabetes question and find a cure for the disease. However, since the research areas address related scientific issues including metabolism, nutrition, lifestyle issues, prevention, health care and nursing, we support research on all diabetes-related diseases.
In 2018, the Diabetes Foundation will spend approximately 25 million kronor on 70 different projects covering the entire medical field, from basic experimental research to patient-related research, nursing science and public health.
– In comparable terms, we do not have much research money to distribute. But we are working intensively to broaden our commitment and find new ways to strengthen patient-related research. In November, the Diabetes Association was organizing a television-broadcasted diabetes gala to raise money for research and raise awareness and knowledge about diabetes. It was very successful and enabled us to increase our research funding, says Fredrik Lundahl.
The Diabetes Association has an ongoing dialogue with representatives of the profession and also supports the National Diabetes Register, which maps and develops diabetes care quality.
– It is a valuable research source. We have worked hard to supplement the register with other types of data such as PROM, patient-reported measures that measure how patients experience their disease and health after treatment or other intervention. There has been a lot of focus on hard medical parameters, but measurements of patients' quality of life and the availability of technical aids, such as insulin pumps and continuous glucose gauges that make an alarm if the glucose value becomes too high or too low, are also needed.
– We would like to see a development of better prevention methods that can reduce the risk of complications, and to find individuals at risk of being sick early. We would also like to see more effective treatment methods and drugs that are better suited for every individual.
– We do not pass patients on to research. But in our journal “All about Diabetes”, we write a lot about research and encourage our members to participate in studies. Furthermore, our member surveys indicate that the interest in research is great. One of the main reasons for being a member is that we engage in research and focus on important issues that can improve diagnostics, care and treatment.
– We would like to have a common platform with major research actors and authorities where we can communicate research information together.
– We would also like to see that Sweden learns from Norway. There, our counterpart to the Diabetes Association has an agreement with the government and the Norwegian Directorate of Health, and receives targeted government grants to carry out certain missions. For example, they have a diabetes hotline with a chat function and a phone advisory service where you can ask questions about diabetes. They also receive grants to start motivation groups for individuals with type-2 diabetes. We would like to see a similar model in Sweden and I think the number of members would increase significantly if we could broaden our business. Today, we are forced to prioritize hard.
Works: Chief District Court Judge at the Administrative Court in Malmö. Chairman of the Swedish Diabetes Association.
Driven by: The opportunity to make a difference and to do it together.
Main issues for the Diabetes Association: Good and equal access to technical aids, support for parents and children in school, better understanding of the diabetic diseases.
Most important research questions: To understand what causes the diabetic diseases.
How to strengthen patient related research: Research must be conducted where patients are present. It is necessary that the entire helthcare system understands the importance of research and provides good conditions for it.
Vision: A life without diabetes.
Worries about: Short-term thinking that characterizes much of today’s society. It does not benefit people with chronic diseases.
Enjoys: My family, good company and football.
Most important question in the forthcoming election: That it is acknowledged how important the parents are to chronically ill kid, so that they have the opportunity to take time off/use contact days if they have to be at school with their kids (but I realize that this is not an election-winning issue).
More than 400 million people in the world are estimated to have diabetes, which is four times more than in 1980. And by 2045, it is expected that the number has increased to 629 million, according to IDF, the International Diabetes Federation.
In Sweden, approximately 450,000 people live with diabetes (the National Diabetes Register). The majority, 85-90 percent, have diabetes type-2. But many people are diagnosed only several years after they have fallen ill and it is expected that every third person with type-2 diabetes is unrecorded.
A much smaller proportion, about 50,000, has diabetes type-1. 7,000 are children. Since the 1980s, the number of children with type-1 diabetes has almost doubled.
In addition to the two main types, there is a number of of less common diseases such as LADA, MODY and secondary diabetes.
Common to the diabetic diseases is a high blood sugar. Without proper treatment, the disease can cause serious complications such as cardiovascular disease, stroke, retinopathy (eye damage), kidney failure (which may require dialysis) as well as reduced blood circulation, which in serious cases can lead to amputation. Complications cause great suffering and are expensive to society. Diabetes can also be the underlying cause of death.
It is still not entirely clear what causes diabetic diseases; more research is required to understand the underlying mechanisms.
In both type-1 and type-2 heredity is involved but it explains only to some extent why people are affected.
In type-1, the body does not produce any insulin, a hormone required for regulation of blood glucose levels.
In type-2, insulin production is insufficient or the effect of insulin in the tissues may be impaired, so-called insulin resistance. The reason for type-2 diabetes is often a combination of both.
It is still not fully understood why insulin production is lacking, becomes insufficient or why the body reacts poorly to insulin.
However, there are several known risk factors that have a high impact on type-2 diabetes, including physical inactivity, overweight and obesity.
Through lifestyle changes such as increased physical activity and dietary changes, there is the possibility, at least initially, to keep the disease in check. When lifestyle changes are not enough, drug treatment may be necessary.
Source: Swedish Diabetes Association
Office for Clinical Studies
Östra Hamngatan 26
SE-411 09 Göteborg
Phone: +46 (0)31 757 41 75
Would you like to subscribe to news, good examples or calendar events from clinicalstudies.se?